166 related articles for article (PubMed ID: 35399021)
1. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
2. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
3. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
[TBL] [Abstract][Full Text] [Related]
4. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
Lopez CL; Waldmann J; Fendrich V; Langer P; Kann PH; Bartsch DK
Langenbecks Arch Surg; 2011 Dec; 396(8):1187-96. PubMed ID: 21805182
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review.
La Salvia A; Sesti F; Grinzato C; Mazzilli R; Tarsitano MG; Giannetta E; Faggiano A
Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681263
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1).
Lopez CL; Joos B; Bartsch DK; Manoharan J; Albers M; Slater EP; Bollmann C; Roth S; Bayer A; Fendrich V
World J Surg; 2019 Mar; 43(3):831-838. PubMed ID: 30600364
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
Bergquist JR; Shariq OA; Li AY; Worth PJ; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinivasa S; Ielpo B; Lopez EV; Norton JA; Lawrence B; Visser BC;
Surgery; 2022 Aug; 172(2):723-728. PubMed ID: 35577612
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
[TBL] [Abstract][Full Text] [Related]
11. Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1.
Lopez CL; Albers MB; Bollmann C; Manoharan J; Waldmann J; Fendrich V; Bartsch DK
World J Surg; 2016 Jul; 40(7):1729-36. PubMed ID: 26956903
[TBL] [Abstract][Full Text] [Related]
12. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms.
Quan L; Liu Y; Cui W; Wang X; Zhang W; Wang Z; Guo C; Lu C; Hu F; Chen X
Lipids Health Dis; 2022 Jul; 21(1):58. PubMed ID: 35842659
[TBL] [Abstract][Full Text] [Related]
13. Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).
Grozinsky-Glasberg S; Lines KE; Avniel-Polak S; Bountra C; Thakker RV
Endocr Relat Cancer; 2020 Sep; 27(9):R345-R355. PubMed ID: 32590358
[TBL] [Abstract][Full Text] [Related]
14. Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.
Bartsch DK; Albers M; Knoop R; Kann PH; Fendrich V; Waldmann J
Neuroendocrinology; 2013; 98(4):290-8. PubMed ID: 24356648
[TBL] [Abstract][Full Text] [Related]
15. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Neuroendocrine Neoplasias in Multiple Endocrine Neoplasia Type 1 Are Predominantly Located in the Dorsal Anlage: An Endoscopic Ultrasound Study.
Kann PH; Scheunemann A; Dorzweiler P; Adelmeyer J; Bergmann S; Goebel JN; Mann V; Bartsch DK; Holzer K; Albers MB; Manoharan J; Scheunemann LM
Pancreas; 2021 Sep; 50(8):1169-1172. PubMed ID: 34714280
[TBL] [Abstract][Full Text] [Related]
17. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1.
Sonoda A; Yamashita YI; Kondo T; Hayashi H; Imai K; Higashi T; Yamamura K; Yamao T; Hashimoto D; Baba H
J Hepatobiliary Pancreat Sci; 2020 Dec; 27(12):984-991. PubMed ID: 32278331
[TBL] [Abstract][Full Text] [Related]
19. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention with Enalapril and Aspirin in Men1(+/T) Knockout Mouse Model.
Manoharan J; Fendrich V; Di Fazio P; Bollmann C; Roth S; Joos B; Mintziras I; Albers MB; Ramaswamy A; Bertolino P; Zhang CX; Slater EP; Bartsch DK; Lopez-Lopez CL
Neuroendocrinology; 2018; 107(3):257-266. PubMed ID: 30025403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
